Abstract
MMPs are a family of Zn dependent endopeptidases, which can mediate degradation of ECM components during various physiological and pathological processes including cancer. Some ECM components, through interaction with integrin receptor and modulation of downstream signaling, are capable of regulating expression and activity of several MMPs. α5β1 integrin is the universally accepted receptor for the ECM component fibronectin (FN). The present review deals with the downstream signaling involved in the α5β1 integrin mediated modulation of expression and activity of MMPs and their effector responses in different cellular system.
Keywords: ECM, Fibronectin, Integrin, MMP, extracellular matrix, matrix metalloproteinase, membrane-type-1 MMP, tissue inhibitor of metalloproteinases, focal adhesion kinase, phosphatidyl-inositol-3-kinase, mitogen activated protein kinase, extracellular regulated kinase.
Anti-Cancer Agents in Medicinal Chemistry
Title:Modulation of MMPs by Cell Surface Integrin Receptor α5β1
Volume: 12 Issue: 7
Author(s): Sekhar Pal, Kirat Kumar Ganguly, Shuvojit Moulik and Amitava Chatterjee
Affiliation:
Keywords: ECM, Fibronectin, Integrin, MMP, extracellular matrix, matrix metalloproteinase, membrane-type-1 MMP, tissue inhibitor of metalloproteinases, focal adhesion kinase, phosphatidyl-inositol-3-kinase, mitogen activated protein kinase, extracellular regulated kinase.
Abstract: MMPs are a family of Zn dependent endopeptidases, which can mediate degradation of ECM components during various physiological and pathological processes including cancer. Some ECM components, through interaction with integrin receptor and modulation of downstream signaling, are capable of regulating expression and activity of several MMPs. α5β1 integrin is the universally accepted receptor for the ECM component fibronectin (FN). The present review deals with the downstream signaling involved in the α5β1 integrin mediated modulation of expression and activity of MMPs and their effector responses in different cellular system.
Export Options
About this article
Cite this article as:
Pal Sekhar, Kumar Ganguly Kirat, Moulik Shuvojit and Chatterjee Amitava, Modulation of MMPs by Cell Surface Integrin Receptor α5β1, Anti-Cancer Agents in Medicinal Chemistry 2012; 12 (7) . https://dx.doi.org/10.2174/187152012802650183
DOI https://dx.doi.org/10.2174/187152012802650183 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glycosylation of Tetraspanin Tspan-1 at Four Distinct Sites Promotes Its Transition Through the Endoplasmic Reticulum
Protein & Peptide Letters Natural Products to Improve Quality of Life Targeting for Colon Drug Delivery
Current Drug Delivery Zn Finger Containing Proteins as Targets for the Control of Viral Infections
Infectious Disorders - Drug Targets The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research A Comparative Analysis of Different Enzyme Immobilization Nanomaterials: Progress, Constraints and Recent Trends
Current Medicinal Chemistry Genes that Modulate the Sensitivity for Anti-Microtubule Drug-Mediated Chemotherapy
Current Cancer Drug Targets Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Current Pharmaceutical Design Withdrawal Notice: Prognosis And Prediction Of Breast Cancer (Bc) Using Growing Mlt (Machine Learning Techniques)
Recent Advances in Computer Science and Communications A Genetic Dissection of Antipsychotic Induced Movement Disorders
Current Medicinal Chemistry Antimicrobial and Structural Properties of Metal Ions Complexes with Thiosemicarbazide Motif and Related Heterocyclic Compounds
Current Medicinal Chemistry Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis
Current Drug Targets Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Current Medicinal Chemistry Surface Markers of Cancer Stem Cells in Solid Tumors
Current Stem Cell Research & Therapy A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib
Anti-Cancer Agents in Medicinal Chemistry Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Recent Patents of microRNAs as Biomarkers for Breast, Leukemia, Prostate and Cervical Cancers
Recent Patents on Biomarkers Is HIV Involved in the Pathogenesis of Non-Infectious Pulmonary Complications in Infected Patients?
Current HIV Research The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry